Agentic AI in Cancer Research
Are you interested in learning more about “agentic” artificial intelligence (AI)?
Join Drs. Dey, Zou, and Natarajan to gain insights into the emergence of AI system and their perspective on where it’s headed, especially as it relates to cancer research.
Unlike rules-based AI assistants and models, agentic AI has the potential to make autonomous decisions (take action on its own). Instead of waiting for queries or data, agentic AI can autonomously monitor and navigate databases, such as electronic health records, to identify issues and propose solutions.
This webinar is part of the Cancer AI Conversations webinar series. Each event short talks from 2–4 experts who offer diverse perspectives on timely and relevant topics related to AI in cancer research. A moderated panel discussion follows each talk.
Can’t attend an upcoming event? Recordings will be available after each session.
Dr. Dey is a distinguished scientist and the executive director of AI oncology and cancer biology at Genentech.
Dr. Natarajan is a research scientist at Google.
Dr. Zou is an associate professor of biomedical data science at Stanford University.
Upcoming Events
- Agentic AI in Cancer ResearchMay 27, 2025BTEC 2025 Annual Conference: The Epidemiology of Brain Metastases for Adult and Pediatric Brain TumorsMay 29, 2025Ctrl+Alt+Cure: Driving Smarter Cancer CareJune 11, 2025NCI Emerging Technologies Seminar: Programs and Resources to Support Technology Development for Cancer ResearchJune 17, 2025Data Jamboree: Enhancing Childhood Cancer Data Sharing and UtilitySeptember 29, 2025 - September 30, 2025NCI Office of Data Sharing’s Annual Data Sharing Symposium 2025: How Data Advances the Impact of Cancer ResearchSeptember 30, 2025 - October 01, 2025